Back to top

Structured education on people at risk of cardiovascular disease (3R Study)

A randomised controlled trial to investigate the effect of structured education on people at risk of cardiovascular disease (3R Study)

What we are doing:

Despite heart disease being a major cause of death in England many people do not know what the risk factors are and how to manage them. We have developed a pragmatic structured education programme for people at high risk of heart disease. The Ready to Reduce Risk Programme is designed to support a healthy lifestyle and improve taking prescribed medicines. The effectiveness of the programme is being assessed in a randomised controlled trial in Northamptonshire.

Why are we doing it:

Many deaths from heart disease could be avoided by people changing their lifestyle habits. Risk factors include high blood cholesterol, high blood pressure, being overweight, not exercising enough, diet smoking and drinking too much alcohol. Also, many people do not take the medicines that they have been prescribed for risk factors such as raised blood pressure and cholesterol. It has been shown that people need information about their own risk factors and to be given the appropriate support to help them understand medications they are prescribed and make relevant lifestyle changes.

What the benefits will be:

The East Midlands experiences high rates of cardiovascular disease (CVD) and the large Black and Minority Ethnic communities in the region have higher than average rates. Developing and implementing an educational programme for people who are already at risk of CVD, will reduce the existing and future risks of CVD, improve patients’ health and reduce NHS costs.

Who we are working with:

This project has been developed in collaboration with a number of partners across the academic and health communities including:

  • Northamptonshire Healthcare NHS Foundation Trust
  • University of Leicester
  • Nene CCG
  • Corby CCG
  • East Midlands Academic Health Science Network (EMAHSN)
  • Janssen

Study leads:

Professor Kamlesh Khunti (Professor of Primary Care Diabetes and Vascular Medicine, University of Leicester) and Dr Stephen Rodgers (General Practitioner and Honorary Senior Lecturer, University of Leicester)

Contact:

Carol Akroyd carol.akroyd@uhl-tr.nhs.uk